The safety and efficacy of iberdomide for the treatment of multiple myeloma

Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, University College London Hospitals, London, UK, briefly discusses the safety and efficacy of iberdomide for the treatment of multiple myeloma. Dr Popat first compares the mechanism of action of iberdomide with that of thalidomide, lenalidomide and pomalidomide, and then discusses the efficacy and tolerability of this novel agent. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.